Lentiviral Mediated
DADA2
anti-TNF
gene therapy
macrophages
stem cells
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
01
2022
accepted:
28
03
2022
entrez:
9
5
2022
pubmed:
10
5
2022
medline:
11
5
2022
Statut:
epublish
Résumé
Deficiency of adenosine deaminase type 2 (DADA2) is an autosomal recessive disease caused by bi-allelic loss-of-function mutations in
Identifiants
pubmed: 35529868
doi: 10.3389/fimmu.2022.852830
pmc: PMC9073084
doi:
Substances chimiques
Intercellular Signaling Peptides and Proteins
0
Tumor Necrosis Factor Inhibitors
0
Adenosine Deaminase
EC 3.5.4.4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
852830Subventions
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 217112/Z/19/Z
Pays : United Kingdom
Informations de copyright
Copyright © 2022 Hong, Casimir, Houghton, Zhang, Jensen, Omoyinmi, Torrance, Papadopoulou, Cummins, Roderick, Thrasher, Brogan and Eleftheriou.
Déclaration de conflit d'intérêts
PB has received institutional grants from: Novartis, SOBI, Roche, Chemocentryx, and Novimmune; consultancy fees from Roche, Novartis and SOBI; and speaker fees from UCB. DE received institutional grants from Lilly, Sobi, Roche and Pfizer. All research at Great Ormond Street Hospital NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health is made possible by the NIHR Great Ormond Street Hospital Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Rheumatology (Oxford). 2021 Sep 1;60(9):4373-4378
pubmed: 33420503
Blood Adv. 2021 Aug 24;5(16):3174-3187
pubmed: 34424322
Hum Gene Ther Clin Dev. 2013 Jun;24(2):77-85
pubmed: 23786330
Blood. 2017 Dec 14;130(24):2682-2688
pubmed: 28974505
J Leukoc Biol. 2010 Aug;88(2):279-90
pubmed: 20453107
N Engl J Med. 2019 Apr 18;380(16):1582-1584
pubmed: 30995379
Clin Exp Immunol. 2004 Jan;135(1):85-93
pubmed: 14678268
Nat Commun. 2019 Apr 9;10(1):1634
pubmed: 30967552
J Allergy Clin Immunol. 2022 May;149(5):1812-1816.e6
pubmed: 34780847
J Am Soc Nephrol. 2012 Jan;23(1):49-62
pubmed: 22052057
J Clin Immunol. 2018 Jul;38(5):569-578
pubmed: 29951947
Curr Opin Pharmacol. 2015 Oct;24:119-27
pubmed: 26363252
J Leukoc Biol. 2022 Feb;111(2):301-312
pubmed: 34730257
Hum Gene Ther. 2021 Jan;32(1-2):43-51
pubmed: 32935622
J Virol. 1998 Nov;72(11):8463-71
pubmed: 9765382
Genome Res. 2001 Jun;11(6):1053-70
pubmed: 11381032
Anal Biochem. 1990 Jun;187(2):268-72
pubmed: 2382828
N Engl J Med. 2014 Mar 6;370(10):921-31
pubmed: 24552285
Arthritis Rheumatol. 2017 Aug;69(8):1689-1700
pubmed: 28493328
Immunol Rev. 2019 Jan;287(1):62-72
pubmed: 30565235
Arthritis Rheumatol. 2016 Sep;68(9):2314-22
pubmed: 27059682
Eur J Immunol. 2021 Jan;51(1):206-219
pubmed: 32707604
Viruses. 2021 Aug 02;13(8):
pubmed: 34452394
Front Immunol. 2019 Jan 14;9:2767
pubmed: 30692987
Biochem J. 2005 Oct 1;391(Pt 1):51-7
pubmed: 15926889
Ann Rheum Dis. 2017 Oct;76(10):1648-1656
pubmed: 28522451
J Leukoc Biol. 2021 Sep;110(3):405-407
pubmed: 34137068
J Rheumatol. 2019 May;46(5):523-526
pubmed: 30647181
N Engl J Med. 2014 Mar 6;370(10):911-20
pubmed: 24552284
Hum Mol Genet. 2019 Oct 1;28(R1):R15-R23
pubmed: 31297531
Front Immunol. 2021 Oct 14;12:754029
pubmed: 34721429
J Clin Immunol. 2021 Oct;41(7):1633-1647
pubmed: 34324127
Mol Ther Methods Clin Dev. 2018 Mar 10;9:257-269
pubmed: 29707600
Nat Commun. 2020 Aug 12;11(1):4034
pubmed: 32788576
J Allergy Clin Immunol. 2020 Jun;145(6):1664-1672.e10
pubmed: 31945408
J Leukoc Biol. 2021 Sep;110(3):409-424
pubmed: 33988272